Dallas, Texas 05/08/2014 (FINANCIALSTRENDS) – Zimmer Holdings, Inc. (NYSE:ZMH) recently announced that its proprietary personalized knee system, Persona® has been selected as finalist for the Medical Design Excellence Awards 2014. This Award is considered the premier program for the medication technology industry.
However, the update did not make any impact on Zimmer Holdings’ stock which traded in red through the yesterday’s session and closed flat at $100.03, about 0.03% down from its previous close. The stock traded within an intra-day range of $98.83 and $100.24. Zimmer Holdings is having market capitalization of $16.99 billion with 167.82 million total shares outstanding.
Senior Vice President and General Manager – Knees for Zimmer Holdings, Inc. (NYSE:ZMH), Stephen E. White announced, “We believe it is recognition of the expertise, effort and energy across the Zimmer Knee team that went into making this product a success for surgeons, institutions and, most importantly, patients. The Persona Knee offers an unparalleled combination of experience and range of innovative features and technologies, in a product system that achieves superior levels of personalization.”
White regarded this as an incredible honor to be named a finalist for Medical Design Excellence Awards while affirming that the company has truly redefined knee replacement with the Persona® system.
About the Awards:
At Medical Design Excellence Awards, entries are judged by a panel of med-tech experts comprised of a balance of practicing doctors, technicians and nurses along with a team of engineers, manufacturers, industrial designers and human factors experts. The entries are comprehensively reviewed based on number of criteria including user-related functions; clinical objectives; innovation in processes, use of materials and components; enhanced end-user benefits; cost-effectiveness; and improved safety, efficacy and accessibility towards responding to a critical unmet clinical need.
Zimmer Holdings, Inc. (NYSE:ZMH) is engaged in the designing, development, manufacturing and marketing of orthopedic devices, dental implants and related surgical products with operations in more than 25 countries. The company housed more than 9,000 employees worldwide.